Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sativex Associated With Behavioral-relapse Prevention Strategy as Treatment for Cannabis Dependence

NCT01747850 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.

NCT NCT01747850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01747850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sativex Associated With Behavioral-relapse Prevention Strategy as Treatment for Cannabis Dependence
Lead sponsor
Centre for Addiction and Mental Health
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2013
Completion date
November 30, 2015
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis dependence